Health and Safety New York launches first cannabis education campaign Public service advertisements started on Monday and will run for approximately three months Natalia Buendia CalvilloApril 5, 2022
Business New York says first pot retail licences should go to people with cannabis convictions The state's Cannabis Control Board voted unanimously Thursday to advance the regulations Kathryn TindaleMarch 10, 2022
News New York to expedite adult-use cannabis production Under a proposed bill, already-authorized hemp farmers will get temporary licences to grow for the recreational market Nick LabaFebruary 17, 2022
Medical and Pharmaceutical New York allows medical pot for any condition at doctors’ discretion Most states only allow doctors to prescribe pot based on a list of qualifying conditions Kathryn TindaleJanuary 25, 2022
News New York’s governor to create US$200M fund for cannabis equity applicants The money will go toward general business support but also direct capital and startup financing Natalia Buendia CalvilloJanuary 5, 2022
News New York won’t issue weed licences until 2023: regulator The state's cannabis law allows for sales to start in 2022, but weed stores won't be selling until mid-2023 Kathryn TindaleNovember 2, 2021
Business First medical cannabis flower hits New York shelves, Curaleaf says The state's cannabis control board announced legislative changes to increase patient access at a meeting Oct. 5 Nick LabaOctober 27, 2021
Medical and Pharmaceutical New York won’t test most workers for weed as cannabis rules progress Regulations have been laid out for weed testing at work and home cultivation for certified medical patients Kathryn TindaleOctober 25, 2021
Legalization New York cannabis board holds first meeting, expands medical access Effective immediately, patients can buy flower, double their held supply and be approved by any practitioner licensed to prescribe medication Nick LabaOctober 5, 2021
News Green Thumb stock drops despite record pot sales With only 8% of the major US pot stock being held by institutional investors, the firm posted revenue of US$194.4 in Q1 Jared GnamMay 13, 2021